EVER Pharma

About EVER Pharma

EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production, and commercialization of products in the areas of neurology and specialty injectables, covering oncology, intensive care and hormone therapeutics.

From our headquarters in Austria, we run a dynamic operation providing innovative products and value-added formulations aimed at enhancing the lives of patients and supporting the work of healthcare professionals through improved convenience and safety.

Our products are developed and manufactured at our EU GMP certified facilities in Austria and Germany. These are highly specialized in the production of complex injectables including high potency and controlled substances, crystal suspensions, as well as oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules.

We market our products in more than 70 countries around the world through our own international affiliates and strategic partners.

  • AT
  • 2015
    On CPHI since
  • 2
  • 1000 - 4999
Company types
Contract Service
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from EVER Pharma (13)

  • Atosiban

    Product Atosiban

    Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labour. Atosiban EVER is indicated to delay imminent pre-term birth in pregnant adult women with a gestational age from 24 until 33 completed weeks...
  • Cabazitaxel EVER Pharma: 45mg/4.5ml + 50mg/5ml + 60mg/60ml - Single liquid vial

    Product Cabazitaxel EVER Pharma: 45mg/4.5ml + 50mg/5ml + 60mg/60ml - Single liquid vial

    Cabazitaxel EVER Pharma is provided as a single vial, ready to dilute formulation and is available in vial sizes covering the common range of patient specifi c doses for economy and convenience Cabazitaxel is a third-generation antineoplastic taxane and was the fi rst therapy to show a survival benefi t f...
  • Contract Manufacturing

    Product Contract Manufacturing

    EVER Pharma is a specialist in the manufacture of complex injectable products such as low oxygen formulations, crystal suspensions and oily solutions. This includes many highly active substances such as narcotics, hormones and cytotoxics.
    Our state-of-the-art facility utilizes the latest innovations i...
  • EVER Pharma Product List

    Product EVER Pharma Product List

    Our products include: • Atosiban • Cabazitaxel • Cebrium® • Cerebrolysin® • Dacepton® • Dexmedetomidine • Docetaxel • Fulvestrant • MemoProve® • Oxytocin • Paclitaxel • Pemetrexed • Tachyben® • Terlipressin
  • EVER Pharma: Product Portfolio

    Product EVER Pharma: Product Portfolio

    Our products include: Atosiban, Cabazitaxel, Cerbrium, Cerebrolysin, Dacepton/Apomorphine, Dexemedetomidine, Docetaxel, Fulvestrant, MemoProve, Oxytocin, Paclitaxel, Pemetrexed, Tachyben, Terlipressin, Trabectedin, Eribulin
  • Pemetrexed EVER Pharma

    Product Pemetrexed EVER Pharma

    Pemetrexed is an antineoplastic chemotherapy drug. It is used in the treatment of malignant mesothelioma and locally advanced or metastatic nonsquamous non-small cell lung cancer. - Available as a ready to dilute liquid formulation – does not require reconstitution from powder saving time and costs. It ca...
  • Terlipressin EVER Pharma

    Product Terlipressin EVER Pharma

    - Ready to use product - for immediate use without reconstitution - Available in vials - safer and more convenient than ampoules - 5ml and new 10ml presentation covering initial and maintenance dose ranges - Additional indication - for Hepato-renal syndrome type I
  • Trabectedin EVER Pharma: 0.25mg + 1.0mg - LYO Vial

    Product Trabectedin EVER Pharma: 0.25mg + 1.0mg - LYO Vial

    - Available in 2 presentations – providing greater flexibility and convenience when preparing patient specific doses - All vial sizes come in CytoWrap® – for safer handling and transportation Description: Trabectedin is an antineoplastic chemotherapy drug. It is indicated as a monotherapy for the treatme...
  • Azacitidine EVER Pharma

    Product Azacitidine EVER Pharma

    Azacitidine is a cytotoxic hypomethylating chemical analogue of cytidine used in the treatment of myelodysplastic syndromes.

    Azacitidine EVER Pharma is available in both the standard 100 mg vial size and a new 150 mg vial size aligned to the most common patient doses to minimize waste...
  • Bortezomib EVER Pharma

    Product Bortezomib EVER Pharma

    Bortezomib is a protease inhibitor indicated for the treatment of progressive or untreated multiple myeloma, and mantle cell lymphoma.

    Bortezomib EVER Pharma is provided as a ready to useformulation for subcutaneous injection (SC), and afterdilution for intravenous injection.
  • Cabazitaxel EVER Pharma

    Product Cabazitaxel EVER Pharma

    Cabazitaxel is a third-generation antineoplastic taxane and was the fi rst therapy to show a survival benefi t for the treatment of patients with docetaxel-refractory mCRPC.

    Cabazitaxel EVER Pharma is provided as a single vial, ready to dilute formulation and is available in vial sizes&nbs...
  • Dexmedetomidine EVER Pharma

    Product Dexmedetomidine EVER Pharma

    Dexmedetomidine is a highly selective alpha-2 adrenergic receptor notable for its ability to provide sedation without the risk of respiratory depression.
    The first Dexmedetomidine in Europe indicated for both ICU and procedural sedation.

EVER Pharma Resources (6)

  • News EVER Pharma receives EU approval for a liquid ready to use Bortezomib formulation

    EVER Pharma is pleased to announce EU-wide approval of Bortezomib for the treatment of patients with multiple myeloma and mantle cell lymphoma
  • Technical Data EVER Pharma: Contract Manufacturing Services

    EVER Pharma offers a wide range of services which includes clinical and commercial supply services. 
    It offers a high level of expertise to support the manufacturing of clinical products from phase I to phase III; prepare and complete PPQ manufacturing and support commercial product for worldwide markets. 

    We are specialized in the manufacture of complex, injectable substances with a special focus on:
    Handling of highly active substances (e.g. narcotics, hormones, cytotoxics)Low-oxygen formulationsCrystal suspensionsOily solutionsWe also offer our customers support for development, regulation, production, and testing:

    Validation, analytical services, and clinical batch manufacturingCommercial manufacture of sterile dosage formsSecondary packaging and storageOptimization of formulations and processesAnalytical testing of sterile dosage formsStability testTechnical advice
    Contact us for more information.
  • Technical Data EVER Pharma: Product list of speciality injectables

    EVER Pharma's products include: Atosiban --  7.5 mg/ml Solution for Injection/InfusionAzacitidine -- 25 mg/ml Powder for Suspension for InjectionCabazitaxel -- 10 mg/ml - Solution for InfusionCerebrolysin® -- 215.2 mg/ml - Solution for Infusion Concentrate for Solution for InfusionDacepton (Apomorphine) -- 5 mg/ml & 10 mg/ml -  Solution for Injection/InfusionDexmedetomidine -- 100 µg/ml - Concentrate for Solution for InfusionDocetaxel -- 20 mg/ml - Concentrate for injectionFulvestrant -- 50 mg/ml - Ready to use pre-filled syringeOxytocin -- 5 IU/ml & 10 IU/ml - Solution for Injection/InfusionPaclitaxel-- 6 mg/ml - Concentrate for InjectionPemetrexed -- 25 mg/ml - Concentrate for Solution for InfusionTerlipressin -- 0.17 mg/ml - Solution for Injection/Infusion
  • Brochure EVER Pharma - CMO Services

    Overview on CMO services offered by EVER Pharma
  • Brochure EVER Pharma - Product List

    Overview on products offered by EVER Pharma
  • Brochure Cabazitaxel EVER Pharma

    45mg/4.5ml + 50mg/5.0ml + 60mg/6ml